AI Friend or Foe: Global Discussion on the Opportunities and Threats of AI in Healthcare and Life Sciences

October 29 @ 11am – 2pm ET

Share:

RSVP to attend

Speakers

Senior Director

Global Medical Affairs

Head of Commercial Excellence and Innovation for Asia

Senior Director, Health AI

Director, Commercial Strategy | Life Sciences and Healthcare

Executive, CTO Lifescience

Director

Mayo Clinic logo Description: All in black. Words at top: "Mayo" underneath "Clinic". Then underthat three interlocking outlines of shields
CEO & Co-Founder

Senior Director, AI

Director of Adaptive Radiotherapy

Managing Partner & Global Chair of Health

Senior Industry Director, Strategic Business Development

Agenda

11:00 AM

AI disruption and its implications for healthcare to enterprise transformation, execution, leadership and sovereignty

Mihai Diga, Executive, CTO Lifescience

11:15 AM

The Missing Data: Can AI Rewrite the Future of Women's Health?

Samah R Ibrahim, Senior Director, Organon

11:30 AM

From AI Hype to Business Impact: Making Innovation Pay Off

Dr. Harsh Shah, Global Director, Commercial Strategy and Value Engineering, Medidata

11:45 AM

Spatial precision medicine - from microscopy to targeted therapies-Tentative title

Dr. Keith Wharton, Global Medical Affairs, Roche

12:00 PM

The AI Advantage: Reinventing Pharma's Commercial Playbook

Vaibhav Rao, Head of Commercial Excellence and Innovation for Asia, Pfizer

12:15 PM

From Copilots to Clinical Impact: What's Next for AI in Healthcare?

Arun Ravi, Senior Director, Health AI, Microsoft

12:30 PM

Go Slow to Go Fast: Ethical AI Implementation at Scale

Ashley Deighan, Director at Mayo Clinic

12:45 PM

Beyond the Pilot: Scaling AI Across the Healthcare Enterprise

Chris Huber Reitz, Senior Director, Enterprise AI, Elevance Health

1:00 PM

When Algorithms Meet the Heart: Can AI Transform Cardiac Care?

Vlastimil Hrabal, CEO & Co-Founder at KARDI AI

1:15 PM

AI vs. Cancer: The Next Frontier in Precision Radiation Therapy

Dr. Stephen Rosenberg, Director of Adaptive Radiotherapy, Moffitt Cancer Center

1:30 PM

New York's AI Opportunity: Powering the Next Wave of Healthcare Innovation

Loretta Beine, Senior Industry Director, Strategic Business Development, Empire State Development

1:45 PM

Session

Gil Bashe, Chair Global Health and Purpose, FINN Partners

1:45 PM

Real-World Evaluation of Stress and Immunology Innovation: Insights from a Clinical Test Site Perspective

Dr. Patrick Wood MD, Coastal Health Practioners

Want to speak, sponsor, or participate more in our events?

Thank you for registering for the event!

We have sent a email confirmation with the Zoom link and add-to-calendar links.

Merck Global Health Innovation

Merck Global Health Innovation Fund (MGHIF) is a growth investor partnering with innovative digital health and data science companies that facilitate and optimize biopharmaceutical operations with the goal of improving patient care.